SMC approves belzutifan for VHL kidney cancer in Scotland
We are delighted to announce that the Scottish Medicines Consortium [...]
We are delighted to announce that the Scottish Medicines Consortium [...]
Immunotherapy combinations are becoming the standard treatment for people with [...]
Kidney cancers often have mutations in a gene called the von Hippel-Lindau [...]
A recent study published in the journal JAMA Oncology has [...]
Axitinib is a medicine for the treatment of advanced kidney [...]
Immunotherapy combinations are becoming the standard treatment after surgery for [...]
TIVO-3 was a phase 3 clinical trial that compared tivozanib, [...]
Adjuvant therapy aims to reduce the risk of the cancer [...]
This study looked at the incidence, diagnosis and treatment of [...]
Further follow-up data from the phase 3 CLEAR study with [...]